Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MYCOF
Recent news which mentions MYCOF
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
October 28, 2024
Tickers
JNJ
MYCOF
NEWS
PFE
Tags
Johnson & Johnson
PTSD
Cannabis
From
Benzinga
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Tickers
ATAI
CMPS
CYBN
HAVLF
Tags
RVVTF
MYCOF
MNMD
From
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Tickers
ATAI
AWKNF
CMND
CYBN
Tags
Financing
Psychedelics Reform
CMND
From
Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Small Cap
Benzinga
PSIL
From
Benzinga
Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market
October 12, 2023
Tickers
MYCOF
Tags
Josh Bartch
Benzinga
Market News
From
Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
Penny Stocks
FLHLF
CMPS
From
Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
August 15, 2023
Tickers
MYCOF
Tags
Markets
Cannabis
financial results
From
Benzinga
Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer
August 01, 2023
Tickers
MYCOF
Tags
Jamaica Psychedelics
Markets
Cannabis
From
Benzinga
Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update
May 30, 2023
Tickers
MYCOF
Tags
Benzinga
Next/Generation Psychedelics
Psychedelics
From
Benzinga
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
May 23, 2023
Tickers
ENVB
FLHLF
IXHL
LSDI
Tags
Benzinga
PSIL
ENVB
From
Benzinga
Mydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated Deficit
May 17, 2023
Tickers
MYCOF
Tags
Penny Stocks
Earnings
mydecine
From
Benzinga
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
May 01, 2023
Tickers
AWKNF
IXHL
MNMD
MSSTF
Tags
TRYPF
Cannabis
Markets
From
Benzinga
New Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive Findings
April 25, 2023
Tickers
MYCOF
Tags
Benzinga
Top Stories
Psychedelics
From
Benzinga
Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More
April 03, 2023
Tickers
MYCOF
Tags
Earnings
MYCOF
News
From
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
Health Canada
SILO
Markets
From
Benzinga
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
December 19, 2022
Tickers
AWKNF
CMND
FLHLF
MYCOF
Tags
Psychedelic/Assisted Therapies
Psychedelics Investing
Penny Stocks
From
Benzinga
Psychedelic Company Sale: Mydecine Gets Over $2.5M For Wholly-Owned Tech Subsidiary Business
December 13, 2022
Tickers
MYCOF
Tags
MYCOF
PanGenomic Health Inc/
M&A
From
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Tickers
AGNPF
BMNDF
CMND
CMPS
Tags
Cannabis
PSYK
Markets
From
Benzinga
Mydecine's Q3 Financials & Update, Sustained Target On Smoking Cessation For Next 12 Months
November 15, 2022
Tickers
MYCOF
Tags
Markets
Cannabis
Benzinga
From
Benzinga
Psychedelics Biotechs Clearmind And Mydecine Share Consolidation And Subscription Agreements
September 26, 2022
Tickers
CMNDF
MYCOF
Tags
Markets
Cannabis
Small Cap
From
Benzinga
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
Tickers
ATAI
AWKNF
CYBN
ENTBF
Tags
ATAI
Cannabis
Guidance
From
Benzinga
Mydecine Innovations Group Reports Q2 Financial Results And Management Updates
August 16, 2022
Tickers
MYCOF
Tags
Psychedelics
Market News
Benzinga
From
Benzinga
Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change
July 19, 2022
Tickers
LOBEF
MYCOF
Tags
Market News
Psychedelics
World Intellectual Property Organization
From
Benzinga
Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved
June 17, 2022
Tickers
MYCOF
Tags
Josh Bartch
News
MYCOF
From
Benzinga
Mydecine Announces 1-for-50 Reverse Stock Split
April 14, 2022
Tickers
MYCOF
Tags
Markets
Cannabis
MYCOF
From
Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
Tickers
ATAI
AWKNF
CYBN
ENVB
Tags
NUMIF
Markets
Small Cap
From
Benzinga
Mydecine Reports Financial Results For 2021
April 01, 2022
Tickers
MYCOF
Tags
Psychedelics
Market News
Benzinga
From
Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
Tickers
CYBN
ENTBF
ENVB
MNMD
Tags
MYCOF
MNMD
ENTBF
From
Benzinga
Mind Medicine to Study Effect of Time on LSD Microdosing
December 17, 2021
Tickers
MNMD
MYCOF
Tags
Biotech
MYCOF
InvestorBrandNetwork
From
Benzinga
Mydecine: Q3 Financials, Advances Research On Psychedelic Therapies For Mental Health & Addiction Disorders
November 16, 2021
Tickers
MYCO
MYCOF
Tags
Cannabis
Topics
Small Business
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.